Thus, strategies designed to induce the expression of in-frame transcripts that lack non-essential exons have the potential to rescue BRCA2 function in mutant cells, setting the basis for preventive interventions in individuals at high risk for hereditary cancer. This evidence concerns the gene BRCA2 and hereditary cancer.